Botanical and plant-derived drugs Market Research Report 2021, Size, CAGR Value, Growth Rate, Latest Trends, Future Demand, Business Investment Plans, SWOT Analysis, Forecast to 2030

In a recently published report, Botanical and plant-derived drugs Market report for till 2030. The report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Botanical and plant-derived drugs Market products.

Click Here to Download Sample Report >> https://www.kennethresearch.com/sample-request-10210489

Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018.

Global Botanical and plant-derived drugs market is valued approximately at USD 31.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.10% over the forecast period 2019-2026. Botanical drugs are derived from medicinal plants. Botanical drugs contain algae vegetable substance, and macroscopic fungi. Botanical and plant derived drugs help in treatment of various diseases, such as central nervous system disorders, infectious diseases cardiovascular diseases, and respiratory diseases. These drugs are used as an important component in medicine and therapies such as homeopathy and ayurvedic medicines. Increasing risk of side effects with the consumption of synthetic drugs such as gastrointestinal upsets, allergic reactions and more, these factors are increasing the demand for botanical and plant derived drugs.

Click Here to Download Sample Report >> https://www.kennethresearch.com/sample-request-10210489

In addition, increasing incidences of chronic diseases are further contributing towards market growth. Increasing adoption of botanical and plant derived drugs in the treatment of respiratory and infectious disease is expected to create significant growth opportunity in the market over the forecast period. For instance, convallaria majalis plant extract is used in for the treatment of cardiovascular disease. Mytesi is a botanical drug approved for the symptom’s relief on noninfectious diarrhea in adults with HIV/AIDS. Also, introduction of medicines made from plants for the treatment of cardiac such as acetyldigoxin, adoniside are also rising adoption of botanical and plant derived drugs. However, stringent laws and regulations for approval of botanical drugs impedes the growth of the market over the forecast period of 2019-2026.


The regional analysis of global Botanical and plant-derived drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high adoption of herbal drugs and technological advances. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing awareness towards botanical and plant derived drugs and increasing prevalence of chronic diseases would create lucrative growth prospects for the Botanical and plant-derived drugs market across Asia-Pacific region.

Major market player included in this report are:
Bayer Healthcare LLC
Abott Laboratories
GlaxoSmithKline plc
Pfizer Inc, Sanofi
Actelion Pharmaceuticals Ltd
Aimil Pharmaceuticals India Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Concordia Pharmaceuticals Inc.
GW Pharmaceuticals plc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By source:
Plant
Algae
Macroscopic fungi
By dosage form:
Pills
Tablets
Capsules
Injection
By Therapeutic applications:
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Botanical and plant-derived drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Click Here to Download Sample Report >> https://www.kennethresearch.com/sample-request-10210489

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

Leonard Thomas is an energetic and versatile freelance writer for 5 years, he pen down any type of articles and web content. he is a Cambridge University Business English Certificate (Europe Level) holder . he is analytical, enthusiastic and ingenious, with the essence to work variously, strives to emerge as a lucrative individual who has a grasp on market. Congenial Interpersonal skills and the competence to grab every single trivia with foolproof analysis is something he primarily posses .

Leave a Reply